Geron | GERN - Market Capitalization

Stock Price
1.65
Daily Change
0.07 4.43%
Monthly
-8.33%
Yearly
-5.17%
Q1 Forecast
1.53

Geron reported $979.3M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 176.25B 24.32B Dec/2025
Bio Techne USD 9.16B 502M Dec/2025
Cassava Sciences USD 141M 54M Sep/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Esperion Therapeutics USD 475M 410M Mar/2026
Exelixis USD 11.75B 959M Dec/2025
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 843M 31M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Novavax USD 1.43B 340M Mar/2026